Medpace
MEDP
672 hedge funds and large institutions have $12.3B invested in Medpace in 2025 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 182 increasing their positions, 273 reducing their positions, and 61 closing their positions.
126% more first-time investments, than exits
New positions opened: 138 | Existing positions closed: 61
100% more funds holding in top 10
Funds holding in top 10: 6 → 12 (+6)
49% more capital invested
Capital invested by funds: $8.28B → $12.3B (+$4.04B)
12% more funds holding
Funds holding: 602 → 672 (+70)
6.41% less ownership
Funds ownership: 91.74% → 85.33% (-6.4%)
33% less repeat investments, than reductions
Existing positions increased: 182 | Existing positions reduced: 273
52% less call options, than puts
Call options by funds: $54.3M | Put options by funds: $113M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$176M |
| 2 |
D.E. Shaw & Co
New York
|
+$112M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$92.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$37.3M |
| 5 |
Goldman Sachs
New York
|
+$36.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$144M |
| 2 |
EIP
Epoch Investment Partners
New York
|
-$140M |
| 3 |
Jane Street
New York
|
-$112M |
| 4 |
Millennium Management
New York
|
-$99.7M |
| 5 |
Two Sigma Advisers
New York
|
-$83M |
MEDP Hedge Fund Activity: Q3 2025 in Review
672 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2025, worth a combined $12.3B — up 49% from $8.28B a quarter earlier.
Buyers outnumbered sellers: 138 funds opened new MEDP positions and 61 closed out — a net gain of 77 holders — while 182 added to existing stakes and 273 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $176M. The largest seller was TD Asset Management, cutting an estimated $144M.
- 672 institutional investors held Medpace (MEDP) as of Q3 2025, up from 602 in Q2 2025.
- Funds reported $12.3B of Medpace stock for Q3 2025, up 49% quarter-over-quarter.
- 138 funds opened new Medpace positions in Q3 2025 and 61 closed out, a net change of +77 holders.
- The largest Medpace buyer in Q3 2025 was AQR Capital Management, an estimated $176M added.
- The largest Medpace seller in Q3 2025 was TD Asset Management, an estimated $144M sold.
Based on aggregated 13F filings for Q3 2025.